<PAGE>
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
FORM 10-Q
(Mark one)
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _____ TO ______
COMMISSION FILE NO: 000-24567
---------
NATROL, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 95-3560780
(State of Incorporation ) (I.R.S. Employer Identification No.)
21411 PRAIRIE STREET
CHATSWORTH, CALIFORNIA 91311
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
(818) 739-6000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
INDICATE BY A CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH
FILING REQUIREMENTS FOR THE PAST 90 DAYS.
YES X NO
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date:
Class Outstanding as of August 1,2000
----- -------------------------------
Common stock, $0.01 par value 13,171,775
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>
PART 1
FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
NATROL, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands except for share and per share amounts)
<TABLE>
<CAPTION>
JUNE 30, DECEMBER 31,
2000 1999
----------- ------------
(UNAUDITED)
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 1,699 $ 485
Accounts receivable, net of allowances of $678 and $503 at
June 30, 2000 and December 31, 1999, respectively 13,716 14,533
Inventories 14,510 15,061
Deferred taxes 1,076 1,076
Income taxes receivable 2,498 --
Prepaid expenses and other current assets 1,656 1,028
-------- --------
Total current assets 35,155 32,183
Property and equipment:
Building and improvements 15,571 15,456
Machinery and equipment 5,473 5,287
Furniture and office equipment 1,797 1,655
-------- --------
22,841 22,398
Accumulated depreciation (3,527) (2,870)
-------- --------
19,314 19,528
Goodwill, net of accumulated amortization of $3,003 and
$1,863 at June 30, 2000 and December 31, 1999,
respectively 38,403 39,543
Other assets 89 98
-------- --------
TOTAL ASSETS $ 92,961 $ 91,352
======== ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Line of credit $ 8,650 $ 1,800
Accounts payable 6,579 7,826
Accrued expenses 1,241 899
Accrued payroll and related liabilities 892 1,688
Income taxes payable -- 182
Current portion of long-term debt 176 161
-------- --------
Total current liabilities 17,538 12,556
Deferred income taxes, non-current 110 110
Long-term debt, less current portion 8,583 8,700
Stockholders' equity:
Common stock 136 135
Additional paid in capital 61,770 61,334
Retained earnings 7,399 9,071
-------- --------
69,305 70,540
Shares held in treasury, at cost (2,021) --
Receivable from stockholder (554) (554)
-------- --------
Total stockholders' equity 66,730 69,986
-------- --------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 92,961 $ 91,352
======== ========
</TABLE>
See accompanying notes
<PAGE>
NATROL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands except for share and per share amounts)
<TABLE>
<CAPTION>
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
---------------------------- ----------------------------
2000 1999 2000 1999
------------ ------------ ------------ ------------
(unaudited) (unaudited)
<S> <C> <C> <C> <C>
Net sales $ 24,083 $ 17,864 $ 46,777 $ 35,701
Cost of goods sold 14,808 8,465 26,720 16,961
------------ ------------ ------------ ------------
Gross profit 9,275 9,399 20,057 18,740
Selling and marketing expenses 9,942 4,545 16,385 8,792
General and administrative expenses 2,713 2,006 5,634 4,033
------------ ------------ ------------ ------------
Total operating expenses 12,655 6,551 22,019 12,825
------------ ------------ ------------ ------------
Operating income (loss) (3,380) 2,848 (1,962) 5,915
Interest income 26 240 43 471
Interest expense (342) (36) (606) (36)
------------ ------------ ------------ ------------
Income (loss) before income tax provision (benefit) (3,696) 3,052 (2,525) 6,350
Income tax provision (benefit) (1,288) 1,181 (854) 2,430
------------ ------------ ------------ ------------
Net income (loss) $ (2,408) $ 1,871 $ (1,671) $ 3,920
============ ============ ============ ============
Basic earnings (loss) per share $ (0.18) $ 0.14 $ (0.13) $ 0.29
Diluted earnings (loss) per share $ (0.18) $ 0.14 $ (0.13) $ 0.29
Weighted average shares outstanding - basic 13,163,430 13,314,880 13,238,175 13,308,443
Weighted average shares outstanding - diluted 13,163,430 13,599,733 13,238,175 13,640,578
</TABLE>
See accompanying notes
<PAGE>
NATROL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands except for share and per share amounts)
(UNAUDITED)
<TABLE>
<CAPTION>
SIX MONTHS ENDED JUNE 30,
2000 1999
--------------------------
<S> <C> <C>
OPERATING ACTIVITIES
Net income (loss) $ (1,671) $ 3,920
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Depreciation and amortization 658 529
Amortization of goodwill 1,140 470
Provision for bad debts 102 105
Shares issued for services 126 --
Changes in operating assets and liabilities:
Accounts receivable 715 (2,409)
Inventories 551 995
Income taxes receivable/payable (2,680) (392)
Prepaid expenses and other current assets (628) (542)
Accounts payable (1,248) (942)
Accrued expenses 342 959
Accrued payroll and related liabilities (796) 431
-------- --------
Net cash provided by (used in) operating activities (3,389) 3,124
INVESTING ACTIVITIES
Purchases of property and equipment (443) (1,312)
Purchases of marketable securities -- (23,302)
Sales of marketable securities -- 18,944
Other assets 8 (12)
-------- --------
Net cash used in investing activities (435) (5,682)
FINANCING ACTIVITIES
Proceeds line of credit borrowings 6,850 --
Repayments on long-term debt (102) --
Purchases of treasury shares (2,021) --
Proceeds from stock purchase plan 45 61
Proceeds from exercise of stock options 266 54
Proceeds from long-term debt -- 3,501
Capitalized loan fees -- (51)
-------- --------
Net cash provided by financing activities 5,038 3,565
-------- --------
Net increase in cash and cash equivalents 1,214 1,007
Cash and cash equivalents, beginning of period 485 559
-------- --------
Cash and cash equivalents, end of period $ 1,699 $ 1,567
======== ========
</TABLE>
See accompanying notes
<PAGE>
NATROL, INC.
NOTES TO CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
(ALL AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
1. BASIS OF PRESENTATION
In the opinion of management, the accompanying unaudited consolidated financial
statements include all necessary adjustments (consisting of normal recurring
accruals) and present fairly the consolidated financial position of Natrol, Inc.
and its subsidiaries (collectively, the "Company" or "Natrol") as of June 30,
2000, and the results of its operations for the three and six months ended June
30, 2000 and 1999 and cash flows for the six months ended June 30, 2000 and
1999, in conformity with generally accepted accounting principles for the
interim financial information applied on a consistent basis. The results of
operations for the three months and six months ended June 30, 2000 are not
necessarily indicative of the results to be expected for the full year.
Certain information and footnote disclosures which are normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been omitted. These financial statements should be read in
conjunction with the audited consolidated financial statements and notes thereto
included in Natrol's December 31, 1999 audited consolidated financial statements
included in the Company's annual report on Form 10-K for the year ended December
31, 1999 as filed with the Securities and Exchange Commission (file number
000-24567).
2. INVENTORIES
Inventories consist of the following:
<TABLE>
<CAPTION>
JUNE 30, DECEMBER 31,
2000 1999
-------- ------------
<S> <C> <C>
Raw material and packaging supplies $6,204 $ 6,440
Finished goods 8,306 8,621
------- -------
$14,510 $15,061
======= =======
</TABLE>
RECLASSIFICATION
Certain reclassifications have been made to the December 31, 1999 balances so
they would be comparable to the current period presentation.
3. COMPREHENSIVE INCOME
The Company's comprehensive income items are not material at June 30, 2000 and
1999, respectively or December 31, 1999, and therefore no disclosures have been
made.
<PAGE>
4. EARNINGS PER SHARE
The Company calculates earnings per share in accordance with SFAS No. 128
"Earnings per share". Basic earnings per share has been computed by dividing net
income by the weighted average number of common shares outstanding. Diluted
earnings per share has been computed by dividing net income by the weighted
average of securities or other contracts to issue Common Stock as if these
securities were exercised or converted to Common Stock. Common Stock equivalent
shares from stock options representing 1,332,400 shares have been excluded from
the computation of diluted earnings per share because the effect would be
antidilutive.
5. STOCKHOLDERS' EQUITY
STOCK OPTIONS
SFAS No. 123, "Accounting for Stock-Based Compensation" encourages, but does not
require, companies to record compensation cost for stock-based employee
compensation plans at fair value. The Company has chosen to continue to account
for stock-based compensation using the intrinsic value method prescribed in
Accounting Principles Board Opinion (APB) No. 25, "Accounting for Stock Issued
to Employees." Please refer to Natrol's prospectus dated July 22, 1998 with the
Securities and Exchange Commission for detail on the Company's Amended and
Restated 1996 Stock Option and Grant Plan ("the Stock Option Plan") and the
related disclosures. During the three months ended June 30, 2000, 450,000
options were granted.
6. LONG-TERM DEBT
In June, 2000 the Company increased its line of credit with Wells Fargo Bank, NA
to $13 million from $10 million.
ITEM 2:
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CERTAIN FACTORS THAT MAY AFFECT FUTURE RESULTS
Information contained or incorporated by reference in this quarterly report on
Form 10-Q and in other SEC filings by the Company contains "forward looking
statements." The Company is including this statement for the express purpose of
availing itself of protections of the safe harbor provided by the Private
Securities Litigation Reform Act of 1995 with respect to all such forward
looking statements. Examples of forward looking statements include, but are not
limited to, the use of forward-looking terminology such as "believes,"
"expects," "may," "will," "should" or "anticipates" or the negative thereof,
other variations thereon, or comparable terminology, or by discussions of
strategy.
The Company's ability to predict results or the effect of certain events on the
Company's operating results is inherently uncertain. Therefore, the Company
wishes to caution each reader of this report to carefully consider the following
factors and certain other factors discussed herein and in other past reports,
including but not limited to the Company's annual report on Form 10-K for the
year ended December 31, 1999, which is filed with the Securities and Exchange
Commission.
Factors that could cause or contribute to the Company's actual results differing
<PAGE>
materially from those discussed herein or for the Company's stock price to be
affected adversely include, but are not limited to: (i) industry trends,
including a potential general downturn or slowing of the growth of the dietary
supplement industry, (ii) increased competition from current competitors and new
market entrants, (iii) adverse publicity regarding the dietary supplement
industry or the Company's products, (iv) the Company's dependence upon its
ability to develop new products,(v) an increase in returns of the Company's
products sold in past years, (vi) the Company's ability to gain or expand
distribution within new or existing accounts and new or existing channels of
trade, (vii) adverse changes in government regulation, (viii) exposure to
product liability claims,(ix) dependence on significant customers, (x) the
Company's ability to keep and attract key management employees, (xi) the
Company's inability to manage growth and execute its business plan, (xii) the
Company's ability to consummate future acquisitions and its ability to integrate
acquired businesses, including without limitation Prolab Nutrition, Inc.
("Prolab"), acquired in October, 1999, and to retain key personnel associated
with any acquisition, (xiii) the absence of clinical trials for many of the
Company's products, (xiv) the Company's inability to obtain raw materials that
are in short supply, (xv) sales and earnings volatility, (xvi) the Company's
ability to manufacture its products efficiently, (xvii) the Company's ability to
manage inventory or sell its inventory before such inventory becomes outdated,
(xxii) the Company experiencing a high rate of product returns, (xix) the
Company's reliance on independent brokers to sell its products, (xx) the
inability of the Company to protect its intellectual property, (xxi) control of
the Company by principal shareholders, (xxii) the possible sale of large amounts
of stock by controlling shareholders, (xxiii) volatility in the stock markets,
(xxiv) a general downturn in the national economy as a whole, and (xxv)
continued market acceptance of Natrol supplements, Laci Le Beau teas, Prolab's
sports nutrition products, and Essentially Pure Ingredients' raw material
products.
RESUTLS OF OPERATIONS
THE FOLLOWING DISCUSSION OF THE RESULTS OF OPERATIONS AND FINANCIAL
CONDITION OF THE COMPANY SHOULD BE READ IN CONJUNCTION WITH THE RESPONSE TO
PART I, ITEM 1 OF THIS REPORT.
THREE MONTHS ENDED JUNE 30, 2000 AND JUNE 30, 1999
NET SALES. Sales are recognized at the time product is shipped. Net sales are
net of discounts, allowances, and estimated returns and credits. Net sales
increased 34.8%, or $6.2 million, to $24.1 million for the three months ended
June 30, 2000 from $17.9 million for the three months ended June 30, 1999. Net
sales during the quarter were adversely affected by returns of approximately $2
million, which were substantially in excess of historical returns for past
quarters. Net sales were also affected by a $1.1 million reduction in private
label business as compared to the second quarter of 1999. The Company's private
label business increased sharply during the last three quarters of 1999 due to
business from one direct marketing firm which, as the Company reported in its
Form 10K for 1999, it considered a non-recurring event. Private label sales,
discounting for the effect of the non-recurring business from the direct
marketing firm, were in line with the Company's past historical performance.
This direct marketing firm accounted for $1.9 million and $1.2 million of the
Company's private label business in the third and fourth quarters of 1999
respectively. Offsetting these negative effects to net sales were $6.0 million
of net sales generated by the Company's Prolab sports nutrition subsidiary which
was acquired in October 1999 and an increase in the Company's other Natrol
business. The Natrol brand continued to suffer during the quarter from a decline
in the Company's herbal category caused primarily by a decline in the sales of
two products, Gingko Biloba and St. John's Wort. These products received
substantial national media
<PAGE>
attention during 1998. During 1999, sales of these products began to decline
industry wide. Sales of these products have declined in each of the last four
quarters. Offsetting the decline in the herbal category and private label sales
were increases in sales from the Company's other products including the
Company's joint care products, in particular MSM and Cetylpure products.
GROSS PROFIT. Gross profit decreased 1.3%, or $124,000, to $9.3 million for the
three months ended June 30, 2000 from $9.4 million for the three months ended
June 30, 1999. Gross margin decreased to 38.5% for the three months ended June
30, 2000 from 52.6% for the three months ended June 30, 1999. Gross margin
declined due to excessive returns, inventory adjustments, and the makeup of the
Company's business. Gross margin from Prolab products are in the 35% to 40%
range which is less than the historical gross margin of the Company's other
business. In addition, returns of approximately $2 million during the quarter
reduced net sales without reducing the cost of goods sold thereby further
decreasing gross margin. During the quarter, the Company also evaluated its
inventory and wrote off short dated inventory that it determined could not be
sold before product expiration dates.
SELLING AND MARKETING EXPENSES. Selling and marketing expenses consist primarily
of advertising and promotional expenses, cost of distribution, and related
payroll expenses and commissions. Selling and marketing expenses increased
118.7%, or $5.4 million, to $9.9 million for the three months ended June 30,
2000 from $4.5 million for the three months ended June 30, 1999. The increase
was primarily due to additional advertising and an increase in sales incentives
and promotional programs with retailers designed to secure shelf space, increase
sales to consumers and support the Company's higher level of sales. Of the total
$5.4 million increase $1.1 million was attributable to the Prolab division.
GENERAL AND ADMINISTRATIVE EXPENSES. General and administrative expenses consist
primarily of personnel costs related to general management functions, finance,
accounting and information systems, research and development expenses, as well
as professional fees related to legal, audit and tax matters and depreciation
and amortization. General and administrative expenses increased 35.2%, or
$707,000, to $2.7 million for the three months ended June 30, 2000 from $2.0
million for the three months ended June 30, 1999. This increase was primarily
attributable to building the infrastructure to support and manage the Company's
growth, including its Prolab, Inc. sports nutrition division acquired in October
1999, with corresponding increases in payroll and depreciation. Additional
goodwill attributable to the acquisition of Prolab amounted to $335,000 in the
quarter.
INTEREST INCOME. Interest income decreased $214,000 to $26,000 for the three
months ended June 30, 2000 from $240,000 for the three months ended June 30,
1999. The decrease was the result of lower average cash balances as a result of
the use of approximately $29 million of cash to complete the purchase of Prolab
in October 1999.
INTEREST EXPENSE. Interest expense increased from $36,000 for the three months
ended June 30, 1999 to $342,000 for the three months ended June 30, 2000. The
increase was due to mortgage debt incurred during the last three quarters of
1999 to purchase the Company's 80,000 sq. ft. headquarters facility as well as a
132,000 sq. ft. shipping facility and to interest payments made on the Company's
short-term borrowings from its line of credit.
INCOME TAX PROVISION. The Company's effective tax rate was reduced to 34.9% in
the second quarter of 2000 from 38.7% in the second quarter of 1999. Due to the
Company's net loss for the three months ended June 30, 2000, the Company
recorded an income tax benefit for the quarter.
<PAGE>
SIX MONTHS ENDED JUNE 30, 2000 AND JUNE 30, 1999
NET SALES. Net sales increased 31.0%, or $11.1 million, to $46.8 million for the
six months ended June 30, 2000 from $35.7 million for the six months ended June
30, 1999. Net sales during the period were affected by returns of approximately
$3.3 million which were substantially in excess of historical returns for past
quarters. Net sales were also affected by a $1.4 million reduction in private
label business as compared to the first six months of 1999. The Company's
private label business increased sharply during 1999 due to business from one
direct marketing firm which, as the Company reported in its Form 10K for 1999,
it considered a non-recurring event. Private label sales, discounting for the
effect of the non-recurring business from the direct marketing firm, were in
line with the Company's past historical performance. This direct marketing firm
accounted for $1.9 million and $1.2 million of the Company's private label
business in the third and fourth quarters of 1999, respectively. Offsetting
those decreases were $12 million of the Company's net sales attributable to
sales from the Company's Prolab, Inc. sports nutrition division which was
acquired in October 1999. The Natrol brand continued to suffer during the first
six months from a decline in the Company's herbal category caused primarily by a
decline in the sales of two products, Gingko Biloba and St. John's Wort. These
products received substantial national media attention during 1998. During 1999,
sales of these products began to decline industry wide. Sales of these products
have declined in each of the last four quarters. Offsetting the decline in the
herbal category and private label sales were increases in sales from the
Company's other products with the largest growth segment being the Company's
joint care products, in particular MSM and Cetylpure products.
GROSS PROFIT. Gross profit increased 7.0%, or $1.3 million, to $20.0 million for
the six months ended June 30, 2000 from $18.7 million for the six months ended
June 30, 1999. Gross margin decreased to 42.9% for the six months ended June 30,
2000 from 52.5% for the six months ended June 30, 1999. Gross margin declined
due to excessive returns, inventory adjustments, and the makeup of the Company's
business. Gross margin from Prolab products are in the 35% to 40% range which is
less than the historical gross margin of the Company's other business.
Approximately $12 million of the Company's net sales was generated from the
Company's lower margin Prolab sports nutrition business. In addition, returns of
approximately $3.3 million during the period reduced net sales without reducing
the cost of goods sold thereby further decreasing gross margin. During the
period, the Company also evaluated its inventory, and wrote off short dated
inventory that it determined could not be sold before product expiration dates.
This expense directly increased product cost and reduced margins.
SELLING AND MARKETING EXPENSES. Selling and marketing expenses consist primarily
of advertising and promotional expenses, cost of distribution, and related
payroll expenses and commissions. Selling and marketing expenses increased
86.4%, or $7.6 million, to $16.4 million for the six months ended June 30, 2000
from $8.8 million for the six months ended June 30, 1999. The increase was
primarily due to additional advertising and an increase in sales incentives and
promotional programs with retailers designed to secure shelf space, increase
sales to consumers and support the Company's higher level of sales.
GENERAL AND ADMINISTRATIVE EXPENSES. General and administrative expenses consist
primarily of personnel costs related to general management functions, finance,
accounting and information systems, research and development expenses, as well
as professional fees related to legal, audit and tax matters and depreciation
and amortization. General and administrative expenses increased 39.7%, or $1.6
million, to $5.6 million for the six months ended June 30, 2000 from $4.0
million for the six months ended June 30, 1999. This increase was primarily
attributable to building the infrastructure to support and manage the Company's
growth
<PAGE>
including its Prolab, Inc. sports nutrition division acquired in October 1999
with corresponding increases in payroll and depreciation. Additional goodwill
attributable to the acquisition of Prolab amounted to $670,000 during the six
month period.
INTEREST INCOME. Interest income decreased $428,000 to $43,000 for the six
months ended June 30, 2000 from $471,000 for the six months ended June 30, 1999.
The decrease is the result of lower average cash balances as a result of the use
of approximately $29 million of cash to complete the purchase of Prolab in
October 1999.
INTEREST EXPENSE. Interest expense increased to $606,000 for the six months
ended June 30, 2000 from $36,000 for the six months ended June 30, 1999. The
increase was due to mortgage debt incurred during the last three quarters of
1999 to finance the purchase of the Company's 80,000 sq. ft. headquarters
facility as well as a 132,000 sq. ft. shipping facility and to interest payments
made on the Company's short-term borrowings from its line of credit.
INCOME TAX PROVISION. The Company's effective tax rate was reduced to 33.8% in
the six months ended June 30, 2000 from 38.3% in the six months ended June 30,
1999. Due to the Company's net loss for the six months ended June 30, 2000, the
Company recorded an income tax benefit for the period.
LIQUIDITY AND CAPITAL RESOURCES
At June 30, 2000, the Company had working capital of $17.6 million, as compared
to $19.6 million in working capital at December 31, 1999. The decrease was
primarily due to an decrease in accounts receivable and inventories and accrued
payables and expenses offset by an increase in income taxes receivable and
prepaid expenses.
Net cash used by operating activities was $3.4 million for the six months ended
June 30, 2000 as compared to $3.1 million of cash provided by operating
activities during the six months ended June 30, 1999. The decrease in cash
provided by operating activities was primarily due to an increase in income
taxes receivable of $2.7 million, an increase of other prepaid expenses of
$627,000, a decrease of accounts payable of $1.2 million and a decrease of
accrued payroll of $796,000. Offsetting these uses of cash were depreciation of
$657,000, amortization of goodwill of $1.1 million, a decrease in accounts
receivable of $715,000, a decrease in inventories of $551,000, an increase in
the provision for bad debts of $102,000 and the exchange of shares of the
Company's stock for services provided of $126,000.
Net cash used in investing activities was $435,000 for the six months ended June
30, 2000 and $5.7 million during the six months ended June 30, 1999. During the
first six months of 2000, the Company invested $443,000 in new plant, property
and equipment which was offset by a reduction in other assets. During the first
six months of 1999, the Company invested $1.3 million in new plant, property and
equipment. In addition, net changes in marketable securities amounted to a net
investment of $4.4 million during the first six months of 1999.
Cash provided by financing activities during the six months ended June 30, 2000
was $5.0 million as opposed to the six months ended June 30, 1999 when financing
activities provided $3.6 million in cash. Net cash provided by financing
activities during the six months ended June 30, 2000 consisted of $6.9 million
from the Company's line of credit, $266,000 the Company received from the
exercise of employee stock options and 45,000 received from the Company's
employee stock purchase plan. These proceeds were offset by the Company's
repurchase of $2 million of stock which it has classified as treasury shares and
<PAGE>
$102,000 of repayments of its long-term debt. Net cash provided by financing
activities during the six months ended June 30, 1999 consisted of $3.5 million
received as a result of the mortgaging of the Company's headquarters facility
located in Chatsworth, California as well as $115,000 from the sale of stock to
employees pursuant to the Company's Stock Purchase Plan as well as the exercise
of stock options by certain employees.
The Company's cash balance at June 30 , 2000 was approximately $1.7 million. The
Company believes that this amount, together with cash generated from operations
and the cash availability from its line of credit, will be sufficient to fund
its anticipated working capital needs and capital expenditures (other than
financing necessary to complete future acquisitions, if any) for at least the
next 12 months. Future acquisitions, if any, would likely require funding with
future borrowings. Future borrowings may include covenants restricting the
Company's ability to issue dividends or to make additional acquisitions. There
can be no assurance that attractive acquisition opportunities will be available
to the Company or will be available at prices and upon such other terms that are
attractive to the Company. The Company regularly evaluates the potential
acquisition of other businesses, products and product lines and may hold
discussions regarding such potential acquisitions. As a general rule, the
Company will publicly announce such acquisitions only after a definitive
agreement has been signed. The Company currently has no commitments or
agreements with respect to any acquisition. In addition, in order to meet its
long-term liquidity needs or consummate future acquisitions, the Company may be
required to incur additional indebtedness or issue additional equity and debt
securities, subject to market and other conditions. There can be no assurance
that such additional financing will be available on terms acceptable to the
Company or at all. The failure to raise the funds necessary to finance its
future cash requirements or consummate future acquisitions could adversely
affect the Company's ability to pursue its strategy and could negatively affect
its operations in future periods.
IMPACT OF INFLATION
Generally, inflation has not had a material impact on the Company's historical
operations or profitability.
ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK
The following discussion about the Company's market risk disclosures involves
forward-looking statements. Actual results could differ materially from those
projected in the forward-looking statements. The Company is exposed to market
risk related to change in interest rates. The Company's long-term debt is at low
fixed rates and its credit facility borrowings are at variable rates and
therefore the Company does not believe it is subject to significant interest
rate risk.
PART II
OTHER INFORMATION
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
a) The 2000 Annual Meeting of Stockholders of Natrol, Inc. (the "Annual
Meeting") was held on June 13, 2000.
b) At the Annual Meeting, the following were re-elected to the Company's Board
of Directors:
<PAGE>
<TABLE>
<CAPTION>
VOTES FOR VOTES WITHHELD
---------- --------------
<S> <C> <C>
P. Andrews McLane 12,498,304 167,922
Kraig Kitchin 12,497,015 169,211
Dennis Griffin 12,498,089 168,317
</TABLE>
The following individuals are members of the Company's Board of Directors whose
terms of office as directors continued after the Annual Meeting":
Elliott Balbert
Dennis Jolicoeur
Norman Kahn
Dennis DeConcini
c) At the Annual Meeting, a proposal to approve an amendment to the Company's
Amended and Restated 1996 Stock Option Grant Plan was approved
<TABLE>
<CAPTION>
VOTES FOR AGAINST ABSTAIN
--------- ------- -------
<C> <C> <C>
10,674,883 934,242 3,935
</TABLE>
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
a.) Exhibits: The following exhibits are filed herewith:
10.1 Amended and Restated 1996 Stock Option and Grant Plan (Incorporated
by reference to Natrol's Proxy file on May 2, 2000).
b.) No reports on Form 8-K were filed during the quarter for which this report
is filed
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
NATROL, INC.
Date: 8/14/00 By: /s/ Elliott Balbert
Chairman, President and Chief Executive Officer
Date: 8/14/00 By: /s/ Dennis R. Jolicoeur
Chief Financial Officer and Executive
Vice President
